Detailansicht

Wissensnetz

Person

Lars Tönges (1974-)

Arzt

Name	Lars Tönges
Zeit	1974- (Lebensdaten)
Ort	Sonstiges Ausland / Unbekanntes Land
Akademischer Grad bzw. Titel	Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Weitere Angaben	Diss. Medizinische Fakultät
Datensatztyp	Person
GND-Nummer	130522228
Datensatz-ID	130522228
Beteiligt an alle anzeigen Guideline “Parkinson’s disease” of the German Society of Neurology (Deutsche Gesellschaft für Neurologie): concepts of care The comorbidity and co-medication profile of patients with progressive supranuclear palsy Data-driven subtyping of Parkinson’s disease: comparison of current methodologies and application to the Bochum PNS cohort Significance of clinical symptoms and red flags in early differential diagnosis of Parkinson’s disease and atypical Parkinsonian syndromes The comorbidity and co-medication profile of patients with progressive supranuclear palsy Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study COVID-19 outcomes in hospitalized Parkinson’s disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice Neurodegeneration - 35 Fallbeispiele aus der Praxis Neurodegeneration – 35 Fallbeispiele aus der Praxis Letter to the editor: risk comorbidities of COVID-19 in Parkinson’s disease patients in Germany Motor, cognitive and mobility deficits in 1000 geriatric patients: protocol of a quantitative observational study before and after routine clinical geriatric treatment – the ComOn-study Specialized Staff for the Care of People with Parkinson’s Disease in Germany: An Overview Parkinson’s Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life Dynamics of device-based treatments for Parkinson’s disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa–carbidopa intestinal gel, and deep brain stimulation Dynamics of Parkinson’s disease multimodal complex treatment in Germany from 2010–2016 : patient characteristics, access to treatment, and formation of regional centers Dynamics of parkinson’s disease multimodal complex treatment in Germany from 2010–2016: patient characteristics, access to treatment, and formation of regional centers Emerging Immunotherapies for Parkinson Disease Upregulation of reggie-1/flotillin-2 promotes axon regeneration in the rat optic nerve in vivo and neurite growth in vitro Generierung und Analyse transgener Mäuse mit Fluoreszenz-markiertem N-Methyl-D-Aspartat-Rezeptor 2D

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Lars Tönges (1974-)

Guideline “Parkinson’s disease” of the German Society of Neurology (Deutsche Gesellschaft für Neurologie): concepts of care

The comorbidity and co-medication profile of patients with progressive supranuclear palsy

Data-driven subtyping of Parkinson’s disease: comparison of current methodologies and application to the Bochum PNS cohort

Significance of clinical symptoms and red flags in early differential diagnosis of Parkinson’s disease and atypical Parkinsonian syndromes

The comorbidity and co-medication profile of patients with progressive supranuclear palsy

Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study

COVID-19 outcomes in hospitalized Parkinson’s disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany

Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice

Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice

Neurodegeneration - 35 Fallbeispiele aus der Praxis

Neurodegeneration – 35 Fallbeispiele aus der Praxis

Letter to the editor: risk comorbidities of COVID-19 in Parkinson’s disease patients in Germany

Motor, cognitive and mobility deficits in 1000 geriatric patients: protocol of a quantitative observational study before and after routine clinical geriatric treatment – the ComOn-study

Specialized Staff for the Care of People with Parkinson’s Disease in Germany: An Overview

Parkinson’s Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life

Dynamics of device-based treatments for Parkinson’s disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa–carbidopa intestinal gel, and deep brain stimulation

Dynamics of Parkinson’s disease multimodal complex treatment in Germany from 2010–2016 : patient characteristics, access to treatment, and formation of regional centers

Dynamics of parkinson’s disease multimodal complex treatment in Germany from 2010–2016: patient characteristics, access to treatment, and formation of regional centers

Emerging Immunotherapies for Parkinson Disease

Upregulation of reggie-1/flotillin-2 promotes axon regeneration in the rat optic nerve in vivo and neurite growth in vitro

Generierung und Analyse transgener Mäuse mit Fluoreszenz-markiertem N-Methyl-D-Aspartat-Rezeptor 2D